In addition, CRNDE expression is modulated via DNA methylation, and CRNDE exhibits protective effects on CLL by preventing CLL progression through the miR-28/NDRG2 axis (Ni et al., 2021). The gene discussed is NDRG2; the disease is B-cell chronic lymphocytic leukemia.